Powered exoskeleton

Exoskeleton Made of Carbon Fiber: Technology Leader German Bionic Unveils New Power Suit

Retrieved on: 
Monday, June 15, 2020
Robotics, Articles, Technology, Industrial robotics, Body armor, Powered exoskeleton, Cray, Robot, Bionics

AUGSBURG, Germany, June 15, 2020 /PRNewswire/ -- The world leader in the development of robotic exoskeletons, German Bionic, presents the latest generation of its smart power suit.

Key Points: 
  • AUGSBURG, Germany, June 15, 2020 /PRNewswire/ -- The world leader in the development of robotic exoskeletons, German Bionic, presents the latest generation of its smart power suit.
  • The flexible Robotics-as-a-Service pricing model makes the Cray X affordable for every company, from small trade workshops to the largest corporations.
  • "With the 4th generation of our connected Cray X robotic exoskeleton, we are once again setting the standards for the entire exoskeleton industry worldwide," says Armin G. Schmidt, CEO of German Bionic.
  • Full product details and information on the flexible pricing plans are available on the German Bionic company website: https://www.germanbionic.com/en/crayx-4/

ReWalk Robotics Reports First Quarter 2020 Financial Results

Retrieved on: 
Thursday, May 28, 2020
Robotics, Assistive technology, Technology, Articles, ReWalk, Medical robotics, Powered exoskeleton, GAAP

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

Key Points: 
  • ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • ReWalk is a registered trademark of ReWalk Robotics Ltd. in Israel and the United States.
  • ReStore is a registered trademark of ReWalk Robotics Ltd. in Europe and an allowed trademark in the United States.
  • ReWalk urges investors to review the reconciliation of the Companys non-GAAP financial measures to the comparable GAAP financial measures included below, and not to rely on any single financial measure to evaluate the Companys business.

ReWalk Robotics to Report First Quarter 2020 Financial Results on May 28, 2020

Retrieved on: 
Tuesday, May 26, 2020
Assistive technology, Technology, Articles, Medical robotics, ReWalk, Prosthetics, Powered exoskeleton, Robotics, Ekso Bionics

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

Key Points: 
  • ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • ReWalks mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
  • Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany.
  • ReWalk is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States.

ReWalk Announces Binding Offer to Deutsche Gesetzliche Unfallversicherung (DGUV) - German Social Accident Insurance

Retrieved on: 
Tuesday, May 12, 2020
Assistive technology, Robotics, Technology, Articles, ReWalk, Medical robotics, Prosthetics, Powered exoskeleton

and YOKNEAM ILIT, Israel and BERLIN, May 12, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, announced the acceptance of the binding offer by DGUV (Deutsche Gesetzliche Unfallversicherung / The German Social Accident Insurance) to provide qualified spinal cord injury (SCI) patients with the ReWalk 6.0 robotic exoskeleton device.

Key Points: 
  • and YOKNEAM ILIT, Israel and BERLIN, May 12, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, announced the acceptance of the binding offer by DGUV (Deutsche Gesetzliche Unfallversicherung / The German Social Accident Insurance) to provide qualified spinal cord injury (SCI) patients with the ReWalk 6.0 robotic exoskeleton device.
  • This binding offer applies for the provision of ReWalk Exoskeletons for all insured persons of the 36 different DGUV members/insurances.
  • Qualified SCI patients who are beneficiaries of DGUV have the opportunity to be supplied with a ReWalk 6.0 exoskeleton for home and community use.
  • "Germany's health care system is a world leader in establishing new standards of care for their population," said Larry Jasinski, CEO of ReWalk.

ReWalk Enters Agreements with Leading German Insurers TK and DAK-Gesundheit to Provide Coverage of Robotic Exoskeletons for Individuals with Spinal Cord Injuries

Retrieved on: 
Thursday, April 23, 2020
Assistive technology, Robotics, Technology, Articles, Medical robotics, Prosthetics, ReWalk, Powered exoskeleton, Spinal cord

These new policies will allow any eligible beneficiary with a spinal cord injury ("SCI") to seek procurement of a ReWalk 6.0 exoskeleton system.

Key Points: 
  • These new policies will allow any eligible beneficiary with a spinal cord injury ("SCI") to seek procurement of a ReWalk 6.0 exoskeleton system.
  • "The agreements with TK and DAK are monumental for national procurement policies for exoskeletons, both in Germany and worldwide," said ReWalk CEO Larry Jasinski.
  • "The advantages of this highly innovative supply have convinced us," said Mr. Thomas Bodmer, Board Member at DAK-Gesundheit.
  • ReWalk Robotics Ltd.develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

Motus Nova Receives Emory University's Annual Entrepreneur For Innovation Award

Retrieved on: 
Friday, April 17, 2020
Robotics, Humans, Body armor, Powered exoskeleton, Emory, Exoskeleton, Branches of biology

Approved as an FDA Class I device for direct sales, Motus Nova has further evolved the device by developing the exoskeletons for home use.

Key Points: 
  • Approved as an FDA Class I device for direct sales, Motus Nova has further evolved the device by developing the exoskeletons for home use.
  • "At Motus Nova, we are making great strides towards eliminating barriers of access to healthcare rehabilitation with a low cost home-based robotic exoskeleton.
  • We are grateful to the Emory Entrepreneur Network and The Emory Alumni Association for the recognition," said David Wu, CEO of Motus Nova.
  • The Emory Entrepreneur Award program was created by alumni volunteers who are passionate about spotlighting the successful products and ventures driven by Emory alumni.

The Weight Is Over: HeroWear, LLC Launches Exoskeleton Technology For All

Retrieved on: 
Tuesday, March 31, 2020
Robotics, Medical robotics, Prosthetics, Powered exoskeleton, Technology

NASHVILLE, Tenn., March 31, 2020 /PRNewswire/ -- HeroWear LLC has launched their revolutionary exosuit today as part of the WeaRAcon 2020 virtual conference.

Key Points: 
  • NASHVILLE, Tenn., March 31, 2020 /PRNewswire/ -- HeroWear LLC has launched their revolutionary exosuit today as part of the WeaRAcon 2020 virtual conference.
  • Designed to fit both men and women, the Apex is a back-assist exoskeleton device that reduces strain on the lower back for benders, lifters and leaners.
  • Researched, developed, and tested at Vanderbilt University, HeroWear's non-powered tech combines robust strength and ease of use.
  • "We believe that many hardworking people of the world could benefit from the power of exoskeleton or exosuit technologies," says CEO and cofounder Mark Harris.

ReWalk Announces Progress with German Statutory Health Insurer to Provide Coverage of Robotic Exoskeletons for Individuals With Spinal Cord Injuries

Retrieved on: 
Wednesday, March 18, 2020
Assistive technology, Robotics, Technology, Articles, ReWalk, Medical robotics, Powered exoskeleton

This agreement, the first in a series of anticipated national policies from German insurers, is expected to have a significant impact for spinal cord injured individuals.

Key Points: 
  • This agreement, the first in a series of anticipated national policies from German insurers, is expected to have a significant impact for spinal cord injured individuals.
  • That addition was a critical turning point, enabling any of Germany's 105 SHIs to pursue national policies for ReWalk procurement.
  • "This is the first in a series of contracts with German insurers that will benefit paralyzed individuals nationwide.
  • ReWalk Robotics Ltd.develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

Join WearRA, ASTM and ASU for Robotics Week

Retrieved on: 
Thursday, February 27, 2020
Robotics, Medical robotics, Industrial robotics, Body armor, Powered exoskeleton

Immediately following WearRAcon, ASTM Committee F48 Exoskeletons and Exosuits will host their biannual meeting, and to round out the week ASU will host the Southwest Robotics Symposium.

Key Points: 
  • Immediately following WearRAcon, ASTM Committee F48 Exoskeletons and Exosuits will host their biannual meeting, and to round out the week ASU will host the Southwest Robotics Symposium.
  • "We are excited to collaborate with ASTM and ASU to bring a full week of robotics education and events to Arizona," said Joseph Hitt, Ph.D., Co-Founder and Executive Director of the Wearable Robotics Association .
  • "These events bring together wearable robotics professionals and entrepreneurs from industry, medical/rehab, academia, and government all in one place."
  • ASU Southwest Robotics Symposium | April 2-3:
    The ASU Southwest Robotics Symposium will focus on three themes this year: Manufacturing and Robotics, Agriculture and Robotics, and Mobility and Robotics.

Ekso Bionics® Announces Collaboration with Kindred Healthcare to Pilot EksoNR in Long-Term Acute Care Hospitals

Retrieved on: 
Tuesday, February 25, 2020
Articles, Health, Robotics, Ekso Bionics, Kindred Healthcare, Medical robotics, Assistive technology, Powered exoskeleton, Rehabilitation hospital, Acute care, Kindred, Hospital

RICHMOND, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced a collaboration with Kindred Healthcare, LLC ("Kindred") to pilot EksoNR the most clinically used robotic exoskeleton, in their long-term acute care hospitals.

Key Points: 
  • RICHMOND, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced a collaboration with Kindred Healthcare, LLC ("Kindred") to pilot EksoNR the most clinically used robotic exoskeleton, in their long-term acute care hospitals.
  • Kindred already offers exoskeleton-assisted rehabilitation with the device in over 20 of its freestanding inpatient Kindred rehabilitation hospitals.
  • Kindred is the first network to explore the benefits of EksoNR in the long-term acute care setting.
  • The pilot began last year and is now being conducted in four of Kindreds long-term acute care hospitals in the Houston-metro area.